India "Needs Law To Stop US Bio-Piracy"

9 July 1997

An Indian newspaper has urged the New Delhi government to enactimmediately stringent legislation making "bio-piracy" an offense.

The National Herald says the developed nations, and particularly the USA, "have been thieving away our resource-rich biodiversity for decades now. It is said that the gene-bank in the USA has stored almost 90% of genes of our plant and animal resources." 90% of plant species have already been patented by outside agencies "without least assertion of ownership rights by the Indian states," it adds.

This "looting" must be stopped by stringent legislation as soon as possible, the Herald says, adding: "this is what the USA does not want. In order to put pressure on India not to enact such a law, the US government has been bullying (India) to accept the unequal intellectual property rights treaty."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight